A highly pure sub-fraction of shallot extract with potent in vitro anti-angiogenic activity
|
Shima Famil Samavati1 , Hamid-Reza Mohammadi-Motlagh 2, Ali Mostafaie3 |
1- Department of Biology, Islamic Azad University, Science and Research Branch, Tehran, Iran. 2- Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. , mohammadimotlagh@gmail.com 3- Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. |
|
Abstract: (8796 Views) |
Abstract Our previous studies showed that various extracts of Persian shallot (Allium hirtifolium) have anti-angiogenic effects. This study has been undertaken to isolate and identify the major effective anti-angiogeneic sub-fraction of shallot. After preparation of the 50% hydroalcoholic extract of shallot bulbs, the extract was successively fractionated into n-hexane, ethyl acetate, n-butanol and aqueous fractions. Anti-angiogenesis activity of fractions was examined by in vitro angiogenesis assay. The ethyl acetate fraction which had the most anti-angiogenesis activity was further fractionated to four sub-fractions by thin layer chromatography (TLC), silica gel column chromatography and then analyzed by High Performance TLC (HPTLC) with ethyl acetate-methanol-water as the solvent system. Our results showed that one of the four sub-fractions, as the major band in HPTLC, had the most anti-angiogenic activity. Purification and characterization of the major anti-angiogenic compound/compounds of shallot's extract may constitute one means by which diets rich in shallot confer protection against cancer and finally introduce new agents with pharmacological activities in shallot as a potential candidate in cancer therapy. |
|
Keywords: Allium hirtifolium, Angiogenesis, Phytochemicals, Cancer, High performance thin layer chromatography |
|
Full-Text [PDF 141 kb]
(3827 Downloads)
|
Type of Study: Original Article |
Subject:
Cancer Received: 2014/07/15 | Accepted: 2014/08/4 | Published: 2014/09/3
|
|
|
|